Effects of lowering dialysate sodium on flow-mediated dilatation in patients with chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 26, Issue 11, 2011, Pages 3678-3682

  Aybal Kutlugün, Aysun ^a   Erdem, Yunus ^a   Okutucu, Sercan ^a   Yorgun, Hikmet ^a   Atalar, Enver ^a   Arici, Mustafa ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

ambulatory blood pressure monitoring; dialysate sodium; endothelial dysfunction; flow mediated dilatation

Indexed keywords

SODIUM;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; DIALYSATE LEVEL; DIALYSIS RELATED SYMPTOM; ENDOTHELIAL DYSFUNCTION; EXCESSIVE INTERDIALYTIC WEIGHT GAIN; FEMALE; FLOW MEDIATED DILATATION; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HUMAN; IATROGENIC DISEASE; MALE; PRIORITY JOURNAL; SODIUM DIALYSATE LEVEL; VASODILATATION; WEIGHT GAIN;

ADULT; BLOOD PRESSURE; BRACHIAL ARTERY; CASE-CONTROL STUDIES; DILATATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEMODIALYSIS SOLUTIONS; HUMANS; HYPOTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; RENAL DIALYSIS; SODIUM; WEIGHT GAIN;

EID: 80155210392     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr092     Document Type: Article

References (43)

1. Kari JA, Donald AE, Vallance DT et al. Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int 1997; 52: 468-472
2. Morris ST, McMurray J, Rodger R, Jardine AG: Impaired endothelium- dependent vasodilatation in uraemia. Nephrol Dial Transplant 2000; 15: 1194-1200
3. Arese M, Strasly M, Ruva C et al. Regulation of nitric oxide synthesis in uraemia. Nephrol Dial Transplant 1995; 10: 1386-1397
4. Morris ST, McMurray JJ, Spiers A et al. Impaired endothelial function in isolated human uremic resistance arteries. Kidney Int 2001; 60: 1077-1082
5. Canaud B, Cristol J, Morena M et al. Imbalance of oxidants and antioxidants in haemodialysis patients. Blood Purif 1999; 17: 99-106
6. Himmelfarb J, Stenvinkel P, Ikizler TA et al. The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002; 62: 1524-1538
7. Dishy V, Sofowora GG, Imamura H et al. Nitric oxide production decreases after salt loading but is not related to blood pressure changes or nitric oxide-mediated vascular responses. J Hypertens 2003; 21: 153-157
8. Keogh JB, Brinkworth GD, Noakes M et al. Effects of weight loss from a very low carbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity. Am J Clin Nutr 2008; 87: 567-576
9. Corretti MC, Anderson TJ, Benjamin EJ et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the international brachial artery reactivity task force. J Am Coll Cardiol 2002; 39: 257-265
10. Celermajer DS, Sorensen KE, Gooch VM et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-1115
11. Hand MF, Haynes WG, Webb DJ. Hemodialysis and L-arginine, but no D-arginine, correct renal-failure associated endothelial dysfunction. Kidney Int 1998; 53: 1068-1077
12. van Guldener C, Janssen MJ, Lambert J et al. Folic acide treatment of hyperhomocysteinaemia in peritoneal dialysis patients: No change in endothelial function after long-term therapy. Perit Dial Int 1998; 18: 282-289
13. Fujiwara N, Osanai T, Kamada T et al. Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension: Modulation of nitric oxide synthesis by salt intake. Circulation 2000; 101: 856-861
14. Fang Y, Mu JJ, He LC et al. Salt loading on plasma asymmetrical dimethylarginine and the protective role of potassium supplement in normotensive salt-sensitive Asians. Hypertension 2006; 48: 724-729
15. Matrougui K, Levy BI, Schiavi P et al. Indapamide improves flow induced dilation in hypertensive rats with a high salt intake. J Hypertens 1998; 16: 1485-1490
16. Boegehold MA. Microvascular structure and function in salt-sensitive hypertension. Microcirculation 2002; 9: 225-241
17. Kimura G, Van Stone JC, Bauer JH. Prediction of postdialysis serum sodium concentration and transcellular fluid shift without measuring body fluid volumes. Artif Organs 1983; 7: 410-415
18. Van Stone JC, Bauer J, Carey J. The effect of dialysate sodium concentration on body fluid compartment volume, plasma renin activity and plasma aldosterone concentration in chronic hemodialysis patients. Am J Kidney Dis 1982; 2: 58-64
19. Mominadam S, Ozkahya M, Kayikcioglu M et al. Interdialytic blood pressure obtained by ambulatory blood pressure measurement and left ventricular structure in hypertensive hemodialysis patients. Hemodial Int 2008; 12: 322-327
20. Middleton RJ, Parfrey PS, Foley RN. Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol 2001; 12: 1079-1084
21. Harnett JD, Kent GM, Barre PE et al. Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol 1994; 4: 1486-1490
22. Locatelli F, di Filippo S, Manzoni C. Relevance of the conductivity kinetic model in the control of sodium pool. Kidney Int 2000; 58 (Suppl. 76): 89-95
23. Yan RT, Anderson TJ, Charbonneau F et al. Relationship between carotid artery intima-media thickness and brachial artery flow-mediated dilation in middle-aged healthy men. J Am Coll Cardiol 2005; 45: 1980-1986
24. Lang RM, Bierig M, Devereux RB et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463
25. Dickinson KM, Keogh JB, Clifton PM. Effects of a low-salt diet on flow-mediated dilatation in humans. Am J Clin Nutr 2009; 89: 485-490
26. Tzemos N, Lim PO, Wong S et al. Adverse cardiovascular effects of acute salt loading in young normotensive individuals. Hypertension 2008; 51: 1525-1530
27. Higashi Y, Sasaki S, Nakagawa K et al. Sodium chloride loading does not alter endothelium-dependent vasodilation of forearm vasculature in either salt-sensitive or salt-resistant patients with essential hypertension. Hypertens Res 2001; 24: 711-716
28. Bragulat E, de la Sierra A, Antonio MT et al. Endothelial dysfunction in salt-sensitive essential hypertension. Hypertension 2001; 37: 444-448
29. Miyoshi A, Suzuki H, Fujiwara M et al. Impairment of endothelial function in salt-sensitive hypertension in humans. Am J Hypertens 1997; 10: 1083-1090
30. Matsuoka H, Itoh S, Kimoto M et al. Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension. Hypertension 1997; 29: 242-247
31. Flanigam MJ. Role of sodium in hemodialysis. Kidney Int 2000; 58 (Suppl 76): 72-78
32. Thein H, Haloob I, Marshall MR. Associations of a facility level decrease in dialysate sodium concentration with blood pressure and interdialytic weight gain. Nephrol Dial Transplant 2007; 22: 2630-2639
33. Davenport A. Audit of the effect of dialysate sodium concentration on inter-dialytic weight gains and blood pressure control in chronic haemodialysis patients. Nephron Clin Pract 2006; 104: 120-125
34. Farmer CKT, Donohoe P, Dallyn PE et al. Low-sodium hemodialysis without fluid removal improves blood pressure control in hemodialysis patients. Nephrology 2000; 5: 237-241
35. Ozturk S, Taymez DG, Bahat G et al. The influence of low dialysate sodium and glucose concentration on volume distributions in body compartments after haemodialysis: A bioimpedance analysis study. Nephrol Dial Transplant 2008; 23: 3629-3634
36. de Paula FM, Peixoto AJ, Pinto LV et al. Clinical consequences of an individualized dialysate sodium prescription in hemodialysis patients. Kidney Int 2004; 66: 1232-1238
37. Ferraboli R, Manuel C, Abensur H et al. Reduction of sodium dialysate for hypertensive HD patients:analysis of beneficial and adverse effects [Abstract]. J Am Soc Nephrol 2002; 13: 211a
38. Krautzig S, Janssen U, Koch KM et al. Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients. Nephrol Dial Transplant 1998; 13: 552-553
39. Ö zkahya M, Toz H, Ozerkan F et al. Impact of volume control on left ventricular hypertrophy in dialysis patients. J Nephrol 2002; 15: 655-660
40. Ozkahya M, Ok E, Cirit M et al. Regression of left ventricular hypertrophy in hemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol Dial Transplant 1998; 13: 1489-1493
41. Chan CT, Jhon SF, Judith AM et al. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 2002; 61: 2235-2239
42. Fagugli RM, Reboldi G, Quintaliani G et al. Short daily hemodialysis: Blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis 2001; 38: 371-376
43. Sayarlioglu H, Erkoc R, Tuncer M et al. Effects of low sodium dialysate in chronic hemodialysis patients: An echocardiographic study. Ren Fail 2007; 29: 143-146